SJCC Swiss-Japanese Chamber of Commerce
 Menu
Investing in Switzerland

Activities

Project “Matterhorn”

Reception of a Japanese Biopharma delegation in Zurich
6 Mai 2026

From 4 to 8 May 2026, delegates from several Japanese Biopharma companies visited Switzerland to learn about the Swiss Biotech ecosystem and to explore potential collaboration or investment opportunities. The visit was organized by Switzerland Global Enterprise through its Swiss Business Hub in Tokyo on the occasion of the Swiss Biotech Day. The special reception on 6 May 2026 was organized and sponsored by the SJCC and EY.

The speakers (from left to right) were: Dominique Ursprung, Senior Lecturer, ZHAW; Board Member, SJCC (facilitator); Takehiro Kinoshita, Sales Manager, GC International AG; Kaspar Zimmerli, Head of Business Development, Switzerland Innovation; André Bieri, Tax Partner and Markets Leader Switzerland, EY; Martin Herb, President of the SJCC; Markus T Schweizer, Client Service Partner, EY; Board Member, SJCC

Webinar: Navigating the tariffs minefield – opportunities for Japanese companies in Switzerland
14 November 2025

In the aftermath of the announcement of new US tariffs in 2025, the SJCC organized a webinar to discuss implications for Japanese companies doing business in Switzerland. Speakers were Dr. Daniel Kalt, Chief Economist, UBS Switzerland, and Markus T Schweizer, Client Service Partner, EY and Board Member, SJCC.

The Future of Health – Building Swiss-Japanese Innovation Partnerships @Expo 2025 Osaka
25 June 2025

Sponsored by the Ambassador of Switzerland to Japan, the Swiss Business Hub in Tokyo organized a Future of Health event on the Expo 2025 campus in Osaka. The aim of the event was to foster new contacts and deepen engagement with key Japanese companies, with the goal of attracting Japanese foreign direct investment (FDI) into Switzerland.

From left to right: Markus T. Schweizer, Partner, EY / Board Member SJCC; Roger Dubach, Ambassador of Switzerland to Japan; Luca Saporita, Consultant Export & Investment Promotion, Swiss Business Hub Japan.

Swiss Biotech Day 2025 – Reception of a Japanese Life Sciences delegation in Switzerland
7 May 2025

From 5 to 9 May 2025, delegates from several Japanese Pharmaceutical and Biopharma companies visited Switzerland to learn about the Swiss Biotech ecosystem and to explore potential collaboration or investment opportunities. The visit was organized by Switzerland Global Enterprise through its Swiss Business Hub in Tokyo, the reception was organized and sponsored by the SJCC and EY.

The speakers (from left to right) were: Dominique Ursprung, Senior Lecturer ZHAW, Board member SJCC; Wieland Noetzold, Senior Executive Officer Sunstar, Vice President SJCC; Liv Minder, Director Global Consulting, Investment Promotion, S-GE;  Martin Herb, President, SJCC; Cyrill Weiss, Director, International Tax and Transaction Services, EY; Markus T Schweizer, Partner, EY.

Reception of a Japanese decarbonization technology innovation delegation in Switzerland
10 September 2024

From 9 to 12 September 2024, delegates from several Japanese industrial companies visited Switzerland to learn about decarbonization innovation technology and to explore potential collaboration or investment opportunities. The business trip was organized by Switzerland Global Enterprise through its Swiss Business Hub in Tokyo and supported by Switzerland Innovation, Trusted Corporation and Swissnex in Japan. The reception was organized and sponsored by the SJCC and EY.

The speakers (from left to right) were: Markus T Schweizer, Partner, EY; Martin Herb, President, SJCC; Sophie Cerny, Deputy CEO, Switzerland Innovation; Gregory Simmonin, Sustainability Leader, Strategy & Transactions, EY; Fariza Abidova, CEO, Trusted Corporation; André Bieri, Markets Leader Switzerland, EY.

Reception of a Japanese Pharma delegation in Switzerland
24 April 2024

During the week of the Swiss Biotech Day, a delegation of 13 Japanese Biopharma companies visited Switzerland. As they are interested to invest in Switzerland or enter into strategic partnerships with other ecosystem players, the SJCC organized an information event and reception for the members of the delegation in Zurich. The event was sponsored by EY and Takeda.

Project «Matterhorn» Activities
The speakers of the event from left to right: Markus T Schweizer, Partner, EY; René Buholzer, CEO, Interpharma; Gabriela Güntherodt, Partner, EY; Sandra Hedinger, Head of External Affairs, Takeda Pharma AG; Martin Herb, President of the SJCC; Thomas Gfeller, CEO, Foundation Switzerland Innovation.